Skip to content

Clinical trials

Completed Phase 1/2 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 1/2 Status: Completed Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20011
20023
20033
20041
20052
20082
20091
20101
20111
20122
20133
20142
20162
20171
20181
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center7
Ariad Pharmaceuticals1
Asan Medical Center1
Baylor College of Medicine1
Cancer Treatment Centers of America1
Chengdu Zenitar Biomedical Technology Co., Ltd1
Constellation Pharmaceuticals1
Drexel University College of Medicine1
Groupe Francophone des Myelodysplasies1
H. Lee Moffitt Cancer Center and Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders36
Myelodysplastic Syndromes21
Leukemia, Myeloid, Acute19
Primary Myelofibrosis17
Leukemia16
Leukemia, Myelomonocytic, Chronic16
Precursor Cell Lymphoblastic Leukemia-Lymphoma14
Thrombocythemia, Essential14
Lymphoma, Non-Hodgkin13
Polycythemia Vera13

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.